Abby Olsen
Adult Health · Battle Creek, MINPI 1821229154
Payments from drug & device makers
Across 130 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Medtronic$328
- Lilly USA, LLC$294
- Abbott$281
- Dexcom, Inc.$227
- Xeris Pharmaceuticals, Inc.$222
- plus $534 from 7 others
What the payments were for
- Food & beverage$2,975100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 64 | $1,088 |
| Medtronic | 7 | $328 |
| Lilly USA, LLC | 11 | $294 |
| Abbott | 11 | $281 |
| Dexcom, Inc. | 4 | $227 |
| Xeris Pharmaceuticals, Inc. | 8 | $222 |
| Insulet Corporation | 14 | $197 |
| Ascensia Diabetes Care US Inc. | 3 | $146 |
| Amgen | 1 | $71 |
| Averitas Pharma Inc. | 4 | $68 |
| Amarin Pharma, Inc. | 1 | $21 |
| Bayer | 1 | $15 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$187
- Ozempic$178
- RYBELSUS$125
- DEXCOM G7 GSS (161)$124
- DEXCOM STELO GLUCOSE BIOSENSOR$124
- MOUNJARO$112
How this compares
$2,975 in reported general payments places this provider in the 85th percentile of 527 adult health providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 101 | $125,541 |
| OzempicSemaglutide | 48 | $100,308 |
| Tresiba Flextouch U-200Insulin Degludec | 58 | $83,825 |
| MounjaroTirzepatide | 74 | $83,181 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 94 | $82,835 |
| TrulicityDulaglutide | 45 | $60,870 |
| RybelsusSemaglutide | 18 | $43,229 |
| EliquisApixaban | 50 | $40,414 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 52 | $39,970 |
| XareltoRivaroxaban | 15 | $22,761 |
| JanuviaSitagliptin Phosphate | 18 | $20,764 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 23 | $19,180 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $10,979 |
| Incruse ElliptaUmeclidinium Bromide | 21 | $10,358 |
| Gvoke Hypopen 2-PackGlucagon | 14 | $8,363 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $1,088 | $150,99287 claims |
| Lilly USA, LLCMounjaro, Trulicity | $294 | $144,052119 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Arexvy, Shingrix | $15 | $102,919151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 527 adult health providers in Michigan.
Other adult health in Battle Creek
- Sheena LedbetterBattle Creek$7K
- Jacqueline BrewerSterling Heights$138K
- Linda Morris McCoyGrand Rapids$59K
- Sarita RaoCanton$51K
- Susanne QuallichAnn Arbor$42K
- Nancy BermanSouthfield$39K
- Michelle MillerQuincy$24K
- Deniene KingAnn Arbor$14K
- Adama JohnsonEastpointe$14K
- Bridget BonelloWyandotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.